Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review

Multidrug-resistant organism (MDRO) infections are a significant cause of morbidity and mortality in solid organ transplant recipients (SOTR), with multidrug-resistant gram-negative bacteria (MDRGNB) infections rising over the past decade. This mini review summarizes current evidence on the epidemiology, diagnostics, and mitigation strategies for MDRGNB in SOTR in the United States. Colonization, most commonly assessed via gastrointestinal surveillance, is dynamic and organism- and organ-dependent, with international meta-analytic data linking MDRO colonization to increased one-year mortality and over a tenfold increased risk of subsequent infection. Progression to active infection, particularly polymicrobial infection, further worsens outcomes, with effects varying by allograft type. Diagnostic approaches include phenotypic (culture-based) and genotypic (molecular) methods; culture-based antimicrobial susceptibility testing remains the gold standard, but delays targeted antibiotic treatment, while molecular assays offer faster turnaround, but are limited by an inability to assign resistance genes to specific pathogens. A combined phenotypic-genotypic approach is recommended for optimal detection of resistance. Proposed mitigation strategies, to date, include active surveillance and infection prevention, targeted perioperative antibiotic prophylaxis, antimicrobial stewardship guided by population-specific antibiograms, and emerging antibiotic-sparing approaches such as fecal microbiota transplant (FMT). Key gaps include the need for organ-specific management protocols, standardized screening practices, and expansion of pediatric and non-liver transplant recipient data.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2026-11-19
DOI
https://doi.org/10.3389/fcimb.2026.1934394
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review

Sanya J. Thomas, Athanasia Meimeteas
Frontiers in Cellular and Infection Microbiology
Antibiotic Resistance in Bacteria
article

Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review

Sanya J. Thomas, Athanasia Meimeteas
article en

Abstract

Multidrug-resistant organism (MDRO) infections are a significant cause of morbidity and mortality in solid organ transplant recipients (SOTR), with multidrug-resistant gram-negative bacteria (MDRGNB) infections rising over the past decade. This mini review summarizes current evidence on the epidemiology, diagnostics, and mitigation strategies for MDRGNB in SOTR in the United States. Colonization, most commonly assessed via gastrointestinal surveillance, is dynamic and organism- and organ-dependent, with international meta-analytic data linking MDRO colonization to increased one-year mortality and over a tenfold increased risk of subsequent infection. Progression to active infection, particularly polymicrobial infection, further worsens outcomes, with effects varying by allograft type. Diagnostic approaches include phenotypic (culture-based) and genotypic (molecular) methods; culture-based antimicrobial susceptibility testing remains the gold standard, but delays targeted antibiotic treatment, while molecular assays offer faster turnaround, but are limited by an inability to assign resistance genes to specific pathogens. A combined phenotypic-genotypic approach is recommended for optimal detection of resistance. Proposed mitigation strategies, to date, include active surveillance and infection prevention, targeted perioperative antibiotic prophylaxis, antimicrobial stewardship guided by population-specific antibiograms, and emerging antibiotic-sparing approaches such as fecal microbiota transplant (FMT). Key gaps include the need for organ-specific management protocols, standardized screening practices, and expansion of pediatric and non-liver transplant recipient data.

Frontiers in Cellular and Infection MicrobiologyVol. 16
Morgan Stanley Children's Hospital (US), Columbia University Irving Medical Center (US)
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon